Seminars in Nephrology
Volume 28, Issue 3 , Pages 252-265 , May 2008

Aquaporin 2 Mutations in Nephrogenic Diabetes Insipidus

  • Anne J.M. Loonen, MSc

      Affiliations

    • Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Nine V.A.M. Knoers, MD, PhD

      Affiliations

    • Department of Human Genetics, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Carel H. van Os, PhD

      Affiliations

    • Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • ,
  • Peter M.T. Deen, PhD

      Affiliations

    • Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    • Corresponding Author InformationAddress reprint requests to Peter M. T. Deen, PhD, 286, Department of Physiology, Radboud University Nijmegen Medical Centre Nijmegen/Nijmegen Centre for Molecular Life Sciences, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

References 

  1. King LS, Agre P. Pathophysiology of the aquaporin water channels. Annu Rev Physiol. 1996;58:619–648
  2. Koyama N, Ishibashi K, Kuwahara M, et al. Cloning and functional expression of human aquaporin8 cDNA and analysis of its gene. Genomics. 1998;54:169–172
  3. Borgnia M, Nielsen S, Engel A, et al. Cellular and molecular biology of the aquaporin water channels. Annu Rev Biochem. 1999;68:425–458
  4. Hara-chikuma M, Verkman AS. Physiological roles of glycerol-transporting aquaporins: the aquaglyceroporins. Cell Mol Life Sci. 2006;63:1386–1392
  5. Knepper MA, Inoue T. Regulation of aquaporin-2 water channel trafficking by vasopressin. Curr Opin Cell Biol. 1997;9:560–564
  6. Nonoguchi H, Owada A, Kobayashi N, et al. Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest. 1995;96:1768–1778
  7. Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP- dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem. 1997;272:14800–14804
  8. Katsura T, Gustafson CE, Ausiello DA, et al. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol. 1997;41:F816–F822
  9. Ishibashi K, Sasaki S, Fushimi K, et al. Immunolocalization and effect of dehydration on AQP3, a basolateral water channel of kidney collecting ducts. Am J Physiol. 1997;41:F235–F241
  10. Kim SW, Gresz V, Rojek A, et al. Decreased expression of AQP2 and AQP4 water channels and Na,K-ATPase in kidney collecting duct in AQP3 null mice. Biol Cell. 2005;97:765–778
  11. Nielsen S, Chou CL, Marples D, et al. Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A. 1995;92:1013–1017
  12. Lande MB, Jo I, Zeidel ML, et al. Phosphorylation of aquaporin-2 does not alter the membrane water permeability of rat papillary water channel- containing vesicles. J Biol Chem. 1996;271:5552–5557
  13. Kamsteeg EJ, Wormhoudt TA, Rijss JPL, et al. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus. EMBO J. 1999;18:2394–2400
  14. Van Balkom BWM, Savelkoul PJ, Markovich D, et al. The role of putative phosphorylation sites in the targeting and shuttling of the aquaporin-2 water channel. J Biol Chem. 2002;277:41473–41479
  15. Christensen BM, Zelenina M, Aperia A, et al. Localization and regulation of PKA-phosphorylated AQP2 in response to V(2)-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol. 2000;278:F29–F42
  16. Werten PJ, Hasler L, Koenderink JB, et al. Large-scale purification of functional recombinant human aquaporin-2. FEBS Lett. 2001;504:200–205
  17. Kamsteeg EJ, Heijnen I, van Os CH, et al. The subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers. J Cell Biol. 2000;151:919–930
  18. Brown D, Katsura T, Gustafson CE. Cellular mechanisms of aquaporin trafficking. Am J Physiol. 1998;275:F328–F331
  19. Klussmann E, Maric K, Rosenthal W. The mechanisms of aquaporin control in the renal collecting duct. Rev Physiol Biochem Pharmacol. 2000;141:33–95
  20. Marples D, Knepper MA, Christensen EI, et al. Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol. 1995;38:C655–C664
  21. Nielsen S, Kwon TH, Christensen BM, et al. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol. 1999;10:647–663
  22. Katsura T, Ausiello DA, Brown D. Direct demonstration of aquaporin-2 water channel recycling in stably transfected LLC-PK1 epithelial cells. Am J Physiol. 1996;39:F548–F553
  23. Digiovanni SR, Nielsen S, Christensen EI, et al. Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci U S A. 1994;91:8984–8988
  24. van Os CH, Deen PMT, Dempster JA. Aquaporins: water selective channels in biological membranes (Molecular structure and tissue distribution). Biochim Biophys Acta. 1994;1197:291–309
  25. Hozawa S, Holtzman EJ, Ausiello DA. cAMP motifs regulating transcription in the aquaporin 2 gene. Am J Physiol. 1996;39:C1695–C1702
  26. Yasui M, Zelenin SM, Celsi G, et al. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am J Physiol. 1997;41:F443–F450
  27. Matsumura Y, Uchida S, Rai T, et al. Transcriptional regulation of aquaporin-2 water channel gene by cAMP. J Am Soc Nephrol. 1997;8:861–867
  28. Albertazzi E, Zanchetta D, Barbier P, et al. Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families. J Am Soc Nephrol. 2000;11:1033–1043
  29. Arthus MF, Lonergan M, Crumley MJ, et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X- linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 2000;11:1044–1054
  30. Hansen LK, Rittig S, Robertson GL. Genetic basis of familial neurohypophyseal diabetes insipidus. Trends Endocrinol Metab. 1997;8:363–372
  31. Rittig S, Siggaard C, Ozata M, et al. Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor. J Clin Endocrinol Metab. 2002;87:3351–3355
  32. Robertson GL, Berl T. Pathophysiology of water metabolism. In:  Brenner BM,  Rector RC editor. Disturbances in control of body fluid and composition. Philadelphia: Saunders; 1995;p. 873–928
  33. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162:1805–1819
  34. Stone KA. Lithium-induced nephrogenic diabetes insipidus. J Am Board Fam Pract. 1999;12:43–47
  35. Schrier RW, Cadnapaphornchai MA, Ohara M. Water retention and aquaporins in heart failure, liver disease and pregnancy. J R Soc Med. 2001;94:265–269
  36. Marples D, Frokiaer J, Nielsen S. Long-term regulation of aquaporins in the kidney. Am J Physiol. 1999;276:F331–F339
  37. Deen PMT, Weghuis DO, Sinke RJ, et al. Assignment of the human gene for the water channel of renal collecting duct aquaporin 2 (AQP2) to chromosome 12 region q12-- >q13. Cytogenet Cell Genet. 1994;66:260–262
  38. Sasaki S, Fushimi K, Saito H, et al. Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest. 1994;93:1250–1256
  39. Mannucci PM, Ruggeri ZM, Pareti FI, et al. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases. Lancet. 1977;1:869–872
  40. Kaufmann JE, Oksche A, Wollheim CB, et al. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest. 2000;106:107–116
  41. Kobrinsky NL, Doyle JJ, Israels ED, et al. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus. Lancet. 1985;1:1293–1294
  42. Bichet DG, Razi M, Lonergan M, et al. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med. 1988;318:881–887
  43. Knoers NVAM, Brommer EJ, Willems H, et al. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron. 1990;54:322–326
  44. Knoers NVAM, Monnens LAH. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney. Eur J Pediatr. 1991;150:370–373
  45. Fushimi K, Uchida S, Hara Y, et al. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature. 1993;361:549–552
  46. Saito F, Sasaki S, Chepelinsky AB, et al. Human AQP2 and MIP genes, two members of the MIP family, map within chromosome band 12q13 on the basis of two-color FISH. Cytogenet Cell Genet. 1995;68:45–48
  47. Deen PMT, Verdijk MAJ, Knoers NVAM, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science. 1994;264:92–95
  48. van Lieburg AF, Verdijk MAJ, Knoers NVAM, et al. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet. 1994;55:648–652
  49. van Lieburg AF, Knoers NVAM, Mallmann R, et al. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene. Nephron. 1996;72:544–546
  50. van Lieburg AF, Verdijk MAJ, Schoute F, et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet. 1995;96:70–78
  51. Moses AM, Sangani G, Miller JL. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J Clin Endocrinol Metab. 1995;80:1184–1186
  52. Brown RM, Fraser NJ, Brown GK. Differential methylation of the hypervariable locus DXS255 on active and inactive X chromosomes correlates with the expression of a human X-linked gene. Genomics. 1990;7:215–221
  53. Deen PMT, Croes H, van Aubel RA, et al. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest. 1995;95:2291–2296
  54. Marr N, Bichet DG, Hoefs S, et al. Cell-biologic and functional analyses of five new aquaporin-2 missense mutations that cause recessive nephrogenic diabetes insipidus. J Am Soc Nephrol. 2002;13:2267–2277
  55. Marr N, Kamsteeg EJ, Van Raak M, et al. Functionality of aquaporin-2 missense mutants in recessive nephrogenic diabetes insipidus. Pflugers Arch. 2001;442:73–77
  56. Mulders SM, Knoers NVAM, van Lieburg AF, et al. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol. 1997;8:242–248
  57. Tamarappoo BK, Verkman AS. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest. 1998;101:2257–2267
  58. Kanno K, Sasaki S, Hirata Y, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995;332:1540–1545
  59. Yang B, Gillespie A, Carlson EJ, et al. Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus. J Biol Chem. 2000;276:2775–2779
  60. Kamsteeg EJ, Deen PMT. Importance of aquaporin-2 expression levels in genotype -phenotype studies in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2000;279:F778–F784
  61. Canfield MC, Tamarappoo BK, Moses AM, et al. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet. 1997;6:1865–1871
  62. Boccalandro C, De Mattia F, Guo DC, et al. Characterization of an aquaporin-2 water channel gene mutation causing partial nephrogenic diabetes insipidus in a Mexican family: evidence of increased frequency of the mutation in the town of origin. J Am Soc Nephrol. 2004;15:1223–1231
  63. De Mattia F, Savelkoul PJ, Bichet DG, et al. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L. Hum Mol Genet. 2004;13:3045–3056
  64. Kamsteeg EJ, Bichet DG, Konings IB, et al. Reversed polarized delivery of an aquaporin-2 mutant causes dominant nephrogenic diabetes insipidus. J Cell Biol. 2003;163:1099–1109
  65. Kuwahara M, Iwai K, Ooeda T, et al. Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus. Am J Hum Genet. 2001;69:738–748
  66. Marr N, Bichet DG, Lonergan M, et al. Heteroligomerization of an aquaporin-2 mutant with wild-type aquaporin- 2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus. Hum Mol Genet. 2002;11:779–789
  67. Mulders SM, Bichet DG, Rijss JPL, et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest. 1998;102:57–66
  68. Afzal AR, Rajab A, Fenske CD, et al. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet. 2000;25:419–422
  69. Vikkula M, Mariman EC, Lui VC, et al. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell. 1995;80:431–437
  70. Wei J, Fish FA, Myerburg RJ, et al. Novel KCNQ1 mutations associated with recessive and dominant congenital long QT syndromes: evidence for variable hearing phenotype associated with R518X. Hum Mutat. 2000;15:387–388
  71. Zhang J, George AL, Griggs RC, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology. 1996;47:993–998
  72. Deen PMT, Rijss JPL, Mulders SM, et al. Aquaporin-2 transfection of Madin-Darby canine kidney cells reconstitutes vasopressin-regulated transcellular osmotic water transport. J Am Soc Nephrol. 1997;8:1493–1501
  73. Procino G, Carmosino M, Marin O, et al. Ser-256 phosphorylation dynamics of aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells. FASEB J. 2003;17:1886–1888
  74. Hirano K, Roth J, Zuber C, et al. Expression of a mutant ER-retained polytope membrane protein in cultured rat hepatocytes results in Mallory body formation. Histochem Cell Biol. 2002;117:41–53
  75. Asai T, Kuwahara M, Kurihara H, et al. Pathogenesis of nephrogenic diabetes insipidus by aquaporin-2 C-terminus mutations. Kidney Int. 2003;64:2–10
  76. Heilker R, Spiess M, Crottet P. Recognition of sorting signals by clathrin adaptors. Bioessays. 1999;21:558–567
  77. Kamsteeg EJ, Savelkoul PJ, Hendriks G, et al. Missorting of the aquaporin-2 mutant E258K to multivesicular bodies/lysosomes in dominant NDI is associated with its monoubiquitination and increased phosphorylation by PKC but is due to the loss of E258. Pflugers Arch. 2007;455:1041–1054
  78. Kamsteeg EJ, Hendriks G, Boone M, et al. Short-chain ubiquitination mediates the regulated endocytosis of the aquaporin-2 water channel. Proc Natl Acad Sci U S A. 2006;103:18344–18349
  79. De Mattia F, Savelkoul PJ, Kamsteeg EJ, et al. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus. J Am Soc Nephrol. 2005;16:2872–2880
  80. Rojek A, Fuchtbauer EM, Kwon TH, et al. Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci U S A. 2006;103:6037–6042
  81. Lloyd DJ, Hall FW, Tarantino LM, et al. Diabetes insipidus in mice with a mutation in aquaporin-2. PLoS Genet. 2005;1:e20
  82. Sohara E, Rai T, Yang SS, et al. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. Proc Natl Acad Sci U S A. 2006;103:14217–14222
  83. McDill BW, Li SZ, Kovach PA, et al. Congenital progressive hydronephrosis (cph) is caused by an S256L mutation in aquaporin-2 that affects its phosphorylation and apical membrane accumulation. Proc Natl Acad Sci U S A. 2006;103:6952–6957
  84. Shi PP, Cao XR, Qu J, et al. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2. Am J Physiol Renal Physiol. 2007;292:F1334–F1344
  85. Zender HO, Ruedin P, Moser F, et al. Traumatic rupture of the urinary tract in a patient presenting nephrogenic diabetes insipidus associated with hydronephrosis and chronic renal failure: case report and review of the literature. Clin Nephrol. 1992;38:196–202
  86. Deen PM. Mouse models for congenital nephrogenic diabetes insipidus: what can we learn from them?. Nephrol Dial Transplant. 2007;22:1023–1026
  87. Earley LE KAHNM, Orloff J. The effects of infusions of chlorothiazide on urinary dilution and concentration in the dog. J Clin Invest. 1961;40:857–866
  88. Kirchlechner V, Koller DY, Seidl R, et al. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child. 1999;80:548–552
  89. Alon U, Chan JC. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol. 1985;5:9–13
  90. Jakobsson B, Berg U. Effect of hydrochlorothiazide and indomethacin treatment on renal function in nephrogenic diabetes insipidus. Acta Paediatr. 1994;83:522–525
  91. Konoshita T, Kuroda M, Kawane T, et al. Treatment of congenital nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride in an adult patient. Horm Res. 2004;61:63–67
  92. Rascher W, Rosendahl W, Henrichs IA, et al. Congenital nephrogenic diabetes insipidus-vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol. 1987;1:485–490
  93. Morello JP, Salahpour A, Laperriere A, et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest. 2000;105:887–895
  94. Bernier V, Lagace M, Lonergan M, et al. Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Mol Endocrinol. 2004;18:2074–2084
  95. Robben JH, Sze M, Knoers NV, et al. Functional rescue of vasopressin V2 receptor mutants in MDCK cells by pharmacochaperones: relevance to therapy of nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2007;292:F253–F260
  96. Robben JH, Knoers NV, Deen PM. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2006;291:F257–F270
  97. Hirano K, Zuber C, Roth J, et al. The proteasome is involved in the degradation of different aquaporin-2 mutants causing nephrogenic diabetes insipidus. Am J Pathol. 2003;163:111–120
  98. Lin SH, Bichet DG, Sasaki S, et al. Two novel aquaporin-2 mutations responsible for congenital nephrogenic diabetes insipidus in Chinese families. J Clin Endocrinol Metab. 2002;87:2694–2700
  99. Tajima T, Okuhara K, Satoh K, et al. Two novel aquaporin-2 mutations in a sporadic Japanese patient with autosomal recessive nephrogenic diabetes insipidus. Endocr J. 2003;50:473–476
  100. Vargas-Poussou R, Forestier L, Dautzenberg MD, et al. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in twelve families with congenital nephrogenic diabetes insipidus. Adv Exp Med Biol. 1998;449:387–390
  101. Carroll P, Al-Mojalli H, Al-Abbad A, et al. Novel mutations underlying nephrogenic diabetes insipidus in Arab families. Genet Med. 2006;8:443–447
  102. Hochberg Z, van Lieburg AF, Even L, et al. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab. 1997;82:686–689
  103. Goji K, Kuwahara M, Gu Y, et al. Novel mutations in aquaporin-2 gene in female siblings with nephrogenic diabetes insipidus: evidence of disrupted water channel function. J Clin Endocrinol Metab. 1998;83:3205–3209
  104. Kuwahara M. Aquaporin-2, a vasopressin-sensitive water channel, and nephrogenic diabetes insipidus. Intern Med. 1998;37:215–217
  105. Li C, Wang W, Kwon TH, et al. Altered expression of major renal Na transporters in rats with unilateral ureteral obstruction. Am J Physiol Renal Physiol. 2003;284:F155–F166
  106. Guyon C, Bissonnette P, Lussier Y, et al. Novel aquaporin-2 (AQP2) mutations responsible for autosomal recessive nephrogenic diabetes insipidus [abstract]. J Am Soc Nephrol. 2004.
  107. Iolascon A, Aglio V, Tamma G, et al. Characterization of two novel missense mutations in the AQP2 gene causing nephrogenic diabetes insipidus. Nephron Physiol. 2007;105:33–41
  108. Moses AM, Scheinman SJ, Oppenheim A. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin. J Clin Endocrinol Metab. 1984;59:1044–1049
  109. Oksche A, Moller A, Dickson J, et al. Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus. Hum Genet. 1996;98:587–589

PII: S0270-9295(08)00049-1

doi: 10.1016/j.semnephrol.2008.03.006

Seminars in Nephrology
Volume 28, Issue 3 , Pages 252-265 , May 2008

Article Tools

* Image Usage & Resolution